XNYS · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Medtronic (MDT) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: Medtronic posted Q4 revenue of $9.8 billion, up 9.9% from $8.93 billion a year ago, beating its own implied guidance by 90 basis points. The results cap what the company calls its strongest annual revenue growth i…
TL;DR: Medtronic filed an officer change disclosure on May 18, 2026, but the available filing text does not identify the executive involved or the nature of the change. Without a named individual or stated role, the stra…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6/8/2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | SELL | -3,961 | $80 | $318,623 |
| 6/8/2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | SELL | -228 | $80 | $18,343 |
| 6/5/2026 | Blomquist Denise L. | Chief Accounting Officer | TAX_WITHHOLD | -237 | $83 | $19,747 |
| 6/4/2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | TAX_WITHHOLD | -6,817 | $83 | $567,992 |
| 6/4/2026 | Martha Geoffrey | Chairman and CEO | TAX_WITHHOLD | -41,936 | $83 | $3,494,108 |
| 6/4/2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | TAX_WITHHOLD | -7,471 | $83 | $622,484 |
| 6/4/2026 | Walter Matthew R. | SVP, Chief HR Officer | TAX_WITHHOLD | -2,840 | $83 | $236,629 |
| 5/26/2026 | Walter Matthew R. | SVP, Chief HR Officer | OPTION_EXERCISE | 9,149 | — | — |
| 5/26/2026 | Walter Matthew R. | SVP, Chief HR Officer | OPTION_EXERCISE | -8,449 | — | — |
| 5/26/2026 | Wall Brett A. | EVP & Pres Neuroscience | OPTION_EXERCISE | 26,907 | — | — |
| 5/26/2026 | Wall Brett A. | EVP & Pres Neuroscience | OPTION_EXERCISE | -24,214 | — | — |
| 5/26/2026 | Martha Geoffrey | Chairman and CEO | OPTION_EXERCISE | 94,963 | — | — |
| 5/26/2026 | Martha Geoffrey | Chairman and CEO | OPTION_EXERCISE | -85,461 | — | — |
| 5/26/2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | OPTION_EXERCISE | 18,994 | — | — |
| 5/26/2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | OPTION_EXERCISE | -17,093 | — | — |
| 5/26/2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | OPTION_EXERCISE | 15,195 | — | — |
| 5/26/2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | OPTION_EXERCISE | -14,517 | — | — |
| 5/26/2026 | Blomquist Denise L. | Chief Accounting Officer | OPTION_EXERCISE | 1,712 | — | — |
| 5/26/2026 | Blomquist Denise L. | Chief Accounting Officer | OPTION_EXERCISE | -1,621 | — | — |
| 5/1/2026 | Walter Matthew R. | SVP, Chief HR Officer | TAX_WITHHOLD | -35 | $80 | $2,800 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 6/8/2026 | KIIL HARRY SKIP | — | 4,189 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 6/26/2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 128,961,343 | $12,388,026,608 | — | 1/29/2026 |
| BlackRock | 111,892,378 | $8,807,049,055 | — | 8/13/2024 |
| State Street | 61,660,158 | $5,966,780,403 | — | 2/13/2026 |
| JP Morgan Chase | 53,616,694 | $5,150,419,786 | — | 2/11/2026 |
| Citadel Advisors | 7,201,188 | $691,746,119 | — | 2/17/2026 |
| Millennium Management | 4,604,488 | $442,307,117 | — | 2/17/2026 |
| AQR Capital | 3,069,104 | $294,818,100 | — | 2/17/2026 |
| Fidelity (FMR) | 2,513,085 | $241,406,866 | — | 2/17/2026 |
| DE Shaw | 1,132,814 | $108,818,112 | — | 2/17/2026 |
| Two Sigma | 1,000,898 | $96,146,262 | — | 2/17/2026 |
| Bridgewater Associates | 282,386 | $27,125,999 | — | 2/13/2026 |
| Point72 | 73,800 | $7,089,228 | — | 2/17/2026 |